Non-myeloablative stem cell transplant (NMSCT) in AML, ALL, and MDS: Disappointing outcome for patients with advanced phase disease.

被引：0
|
作者：
Rezvani, K
Lalancette, M
Szydlo, R
Mackinnon, S
Blaise, D
Slavin, S
Alessandrino, EP
Michallet, M
Niederwieser, N
Apperley, J
Frassoni, F
机构：
[1] Hammersmith Hosp, London, England
[2] UCL, London, England
[3] Inst J Paoli I Calmettes, F-13009 Marseille, France
[4] Hadassah Univ, Jerusalem, Israel
[5] Policlin San Matteo, I-27100 Pavia, Italy
[6] Hop Edouard Herriot, Lyon, France
[7] Univ Leipzig, D-7010 Leipzig, Germany
[8] Osped San Martino Genova, Genoa, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2061
引用
收藏
页码：479A / 479A
页数：1
相关论文
共 50 条
  • [31] Non-Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease
    Saraf, Santosh
    Patel, Pritesh Rajni
    Sweiss, Karen
    Oh, Annie
    Koshy, Matthew
    Campbell-Lee, Sally
    Gowhari, Michel
    Jain, Shivi
    Peace, David
    Quigley, John
    Khan, Irum
    Molokie, Robert
    Mahmud, Nadim
    Gordeuk, Victor
    Rondelli, Damiano
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S59 - S59
  • [32] TRANSFUSION SUPPORT OF PEDIATRIC SICKLE CELL DISEASE PATIENTS UNDERGOING NON-MYELOABLATIVE STEM CELL TRANSPLANTATION
    Collier, Israel
    Wong, Edward
    Tekle, Medhanite
    Fasano, Ross
    Paul, Wendy
    Luban, Naomi
    Sande, Jane
    Kamani, Naynesh
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (03) : 632 - 633
  • [33] Major ABO Incompatibility in Non-Myeloablative Hematopoietic Stem Cell Transplant for Sickle Cell Disease-Not an Insurmountable Obstacle
    Chung, Kimberly Ji Eun
    Wall, Donna A.
    Chiang, Kuang-Yueh
    PEDIATRIC BLOOD & CANCER, 2025, 72 (04)
  • [34] ATG in non-myeloablative stem cell transplant: a national dose-finding study
    Bron, D
    Zachee, P
    Maertens, J
    Doyen, C
    Noens, L
    Meuleman, N
    Theunissen, K
    Ferrant, A
    Selleslag, D
    Schroyens, W
    Demuynck, H
    Boogaerts, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S151 - S151
  • [35] Hypogammaglobulinemia following non-myeloablative allogeneic stem cell transplant correlates with chimerism.
    Bolwell, BJ
    Pohlman, B
    Sobecks, R
    Andresen, S
    Rybicki, L
    Kuczkowski, E
    Jarvis, J
    Koennecke, J
    Bernhard, L
    Ostendorf, H
    Bell, K
    Serafino, S
    Theil, K
    Kalaycio, M
    BLOOD, 2001, 98 (11) : 353B - 353B
  • [36] Microbiota analysis in allogeneic stem cell transplant patients with in AML and MDS
    Gurer, Ekin Ece
    Oguz, Fatma Savran
    Aktas, Zerrin
    Kalayoglu, Sevgi Besisik
    Oncul, Mustafa Oral
    Sezerman, Osman Ugur
    Ekren, Berkay
    Caliskan, Kader
    Gulbas, Zafer
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 326 - 326
  • [37] Allogeneic non-myeloablative peripheral-blood stem cell transplant in solid tumors
    Peccatori, J
    Bregni, M
    TUMORI, 2002, : S32 - S33
  • [38] Non-myeloablative stem cell transplantation in beta thalassaemia major patients
    Ghavamzadeh, A
    Mousavi, A
    Iravani, M
    Bahar, B
    Gholibeikian, S
    Moradiseresht, M
    Heydari, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S107 - S107
  • [39] Non-myeloablative allogeneic stem cell transplant in a patient with refractory systemic lupus erythematosus
    Lu, Q
    Lu, L
    Niu, X
    Guo, Y
    Parino, GR
    Liu, D
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 979 - 981
  • [40] Durable complete remission of primary granulocytic sarcoma by non-myeloablative stem cell transplant
    Tan, D
    Wong, GC
    Hwang, W
    Loh, Y
    Koh, LP
    Goh, YT
    Tan, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S343 - S344
12345